Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT02240875
What this trial is testing

Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Who this might be right for
EbolaEbola Zaire
University of Oxford 91
Not applicableStudy completedNCT03140774
What this trial is testing

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Who this might be right for
Ebola Virus Disease
University of Oxford 126
Not applicableUnknownNCT05888649
What this trial is testing

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Who this might be right for
Ebola Virus Disease
UL-PIRE Africa Center 1,500
Early research (Phase 1)UnknownNCT02296983
What this trial is testing

Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Large-scale testing (Phase 3)Study completedNCT02543268
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Crucell Holland BV 329
Not applicableAvailableNCT05067166
What this trial is testing

Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP

Who this might be right for
Ebola Virus Disease
Ridgeback Biotherapeutics, LP
Early research (Phase 1)Study completedNCT02231866
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 143
Testing effectiveness (Phase 2)Study completedNCT02876328
What this trial is testing

Partnership for Research on Ebola VACcinations

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,789
Not applicableNot Yet RecruitingNCT07681752
What this trial is testing

Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA

Who this might be right for
Ebola Hemorrhagic FeverLassa Hemorrhagic Fever
Institute of Tropical Medicine, Belgium 150
Not applicableStudy completedNCT06811129
What this trial is testing

Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia

Who this might be right for
EbolaPost-Acute Ebola Syndrome
National Institute of Neurological Disorders and Stroke (NINDS) 328
Large-scale testing (Phase 3)Study completedNCT02378753
What this trial is testing

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Who this might be right for
Hemorrhagic Fever, Ebola
Centers for Disease Control and Prevention 8,651
Testing effectiveness (Phase 2)Study completedNCT05817422
What this trial is testing

Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 126
Testing effectiveness (Phase 2)Study completedNCT02575456
What this trial is testing

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Who this might be right for
Ebola Disease
Jiangsu Province Centers for Disease Control and Prevention 500
Testing effectiveness (Phase 2)Study completedNCT05284097
What this trial is testing

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Who this might be right for
Virus DiseasesHemorrhagic Fever, EbolaInfections+8 more
London School of Hygiene and Tropical Medicine 133
Early research (Phase 1)Ended earlyNCT02041715
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 21
Large-scale testing (Phase 3)Study completedNCT03161366
What this trial is testing

Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Epicentre 500
Testing effectiveness (Phase 2)Study completedNCT04028349
What this trial is testing

ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)

Who this might be right for
Ebola Virus Disease
MRC/UVRI and LSHTM Uganda Research Unit 800
Early research (Phase 1)Study completedNCT02408913
What this trial is testing

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 140
Next Page